3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
2
Anatomic Stage IV Breast Cancer AJCC v8
2
Myasthenia Gravis
1
Lymphoma, Follicular
1
Lymphoma
1
Carcinoma, Intraductal, Noninfiltrating
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
rozanolixizumab
8
zilucoplan
7
ravulizumab
6
fludarabine
5
efgartigimod alfa
5
Cyclophosphamide
5
telitacicept
3
Prednisone
3
inebilizumab
2
Rituximab
2
Pyridostigmine Bromide
2
tofacitinib
1
thymoglobulin
1
talquetamab
1
remibrutinib
1
prednylidene
1
iptacopan
1
eculizumab
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Walk Test
1
Therapeutics
1
Tacrolimus
1
Steroids
1
Robotic Surgical Procedures
1
Psychodrama
1
Prednisolone
1
Plasma Exchange
1
Peripheral Blood Stem Cell Transplantation
1
Oxaloacetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myasthenia Gravis
×
Steroids
×
1 year
×
Clear all
NCT04182984
2026-01-30
TREAT-OMG
Tang-Du Hospital
Recruiting
200 enrolled